Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial
Introduction Bronchiectasis is a worldwide chronic lung disorder where exacerbations are common. It affects people of all ages, but especially Indigenous populations in high-income nations. Despite being a major contributor to chronic lung disease, there are no licensed therapies for bronchiectasis...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
BMJ Publishing Group
2024
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/45258/ https://doi.org/10.1136/bmjresp-2023-002216 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|